2OK vs ARCOMA: Side-by-Side Comparison
Compare SPECTRACURE AB (2OK) and Arcoma AB (ARCOMA) side by side: market cap EUR 57.06K vs SEK 120.19M. Financials, growth and model signals on Bullrun.
| Metric | 2OK | ARCOMA |
|---|---|---|
| Company | SPECTRACURE AB | Arcoma AB |
| Country / Exchange | Sweden · F | Sweden · ST |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
| Market cap | EUR 57.06K | SEK 120.19M |
| P/E ratio | — | 32.3 |
| Dividend yield | — | — |
| Valuation model | — | 1.4% undervalued |
| Revenue (latest FY) | — | — |
| Revenue growth YoY | — | — |
| Net income | — | — |
| Gross margin | — | — |
| Diluted EPS | — | — |